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JEAN D. SRAER, JOSEE SRAER, RAYMOND ARDAILLOU and ODILE MIM0uNE
Unite de Recherches de l'INSERM, U64, Hôpital Tenon, Paris, France
Evidence for renal glomerular receptors for angiotensin II.
Monoiodinated angiotensin 11(2000 mCi/imo1e) was found to
bind specifically to isolated rat glomeruli. Equilibrium was
reached after 12 mm and specific binding represented more than
95% of total binding. Dissociation after addition of an excess of
unlabelled molecules was rapid. The k1 and k1 association and
dissociation constants determined from time-course studies were
0.254±0.078 x 10° M1 min' and 0.102±0.018 min1, respec-
tively and the ratio k_1/k1 (KD) was 4.51±0.55x 10_li M.
Angiotensin 11, liberated from glomerular binding sites at low pH,
retained the ability to bind to fresh membranes. Angiotensin II,
angiotensin I, ileu8-angiotensin II and sarc1-ileu8-angiotensin II
were all equally effective as competitive inhibitors of 1251..
angiotensin binding. In a preparation of isolated rat glomeruli,
mean glomerular diameter decreased as a function of 12iJ.
angiotensin II concentration according to a sigmoidal effect vs.
log dose curve and the calculated K (6x 10 M) was similar
to that obtained from binding studies. Specific binding of angio-
tensin II at physiological plasma concentration to rat glomeruli
and correlation of this binding with glomerular vasoreactivity
suggest a physiological role for this hormone in regulation of
glomerular filtration.
Récepteurs rénaux glomérulaires de l'angiotensine II. L'Angio-
tensine II monoiodée (2000 mCi/smole) se lie spécifiquement
aux glomérules de rat isolés. L'équilibre est atteint au bout de
12 mn et Ia fixation spécifique représente plus de 95% de Ia fixa-
tion totale. L'addition d'un excès d'angiotensine non marquee
determine une dissociation rapide de l'hormone fixée. Les con-
stantes d'association (k1) et de dissociation (k_1) calculées a
partir des experiences de fixation en fonction du temps sont
egales a 0,254±0,078x 1010 M1 mn1 et 0,102±0,018 mn',
respectivement. Le rapport k_1/k1 (KD) est égal a 4,51±0,55x
10_il M. L'angiotensine II, éluée a pH acide de ses sites glomeru-
laires de liaison, garde la capacité de se her de nouveau a des
membranes fraiches. L'angiotensine II, l'angiotensine I, la
ileu8-angiotensine II et Ia sarc'-ileu8-angiotensine II sont des in-
hibiteurs compétitifs de la 1251-angiotensine II, tous de méme
efficacité. Le diamètre glomérulaire moyen mesuré dans une
preparation de glomerules isolés décroit en fonction de la con-
centration de la '251-angiotensine II selon une courbe sigmoide
(effet contre le log de Ia dose) et le KD calculé (6 x lO M) est
semblable a celui obtenu a partir des experiences de liaison. La
fixation spécifique aux glomérules de rat de l'angiotensine ii a
des concentrations identiques a celles présentes physiologique-
ment dans le plasma, ainsi que la correlation entre la liaison de
l'hormone aux glomérules et Ia vasomotricité glomérulaire
suggèrent un role physiologique de l'angiotensine II dans Ia
filtration glomerulaire.
Received for publication February 5, 1974;
and in revised form June 5, 1974.
© 1974, by the International Society of Nephrology.
241
Angiotensin II modifies urinary excretion of sodium
in the rat [1] and may have a role in regulation of
glomerular filtration [2]. Further, shrinkage of glome-
rular tufts has been observed under scanning micros-
copy after angiotensin II administration in the rat [3].
Glomerular receptors for angiotensin II have been
postulated by Osborne et al [4] who, using autoradio-
graphy, observed localization of tritiated angiotensin II
in rat mesangial cells after i.v. injection. This study
presents evidence for specific angiotensin II receptors
in rat glomeruli and for angiotensin If-induced media-
tion of glomerular vasoreactivity.
Methods
Materials. cz-L-asparaginyl1-valyl5-angiotensin II was
labelled with 125J to a specific activity of the order of
50 l.LCi/.g by the method of Hunter and Greenwood [5]
with minor modifications. Labelled and unlabelled
molecules were separated using polyacrylamide gel
electrophoresis according to the method of Corvol
et al [6]. The specific activity of the labelled hormone
was calculated in a radioimmunoassay system with pro-
gressively increasing doses of either labelled or un-
labelled hormones. Linear transformation was ob-
tained by plotting logit B/BO against loge X, where
B0 =bound hormone for zero dose, B bound hor-
mone for any dose and X =dose of either labelled or
unlabelled angiotensin II. Statistical analysis as used
in biological assays [7] demonstrated the linearity and
parallelism of both curves and enabled calculation of
the ratio cpm over pg which corresponded to 2200 mCi!
mole. This value is very close to the theoretical
specific activity of one atom of iodine per mole of
angiotensin II. Angiotensin I was obtained from
Schwarz-Mann (Orangeburg, NY, U.S.A.). Sarc1-
ileu8-angiotensin II and 1—34 bovine parathyroid hor-
mone were purchased from Beckman (Palo Alto, CA,
U.S.A.).
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Preparation of isolated glomeruli [8]. Rats weighing
approximately 120 g (Charles River strain) were
anesthetized with ether. Bilateral nephrectomy was
performed without renal artery perfusion. The outer
cortex was dissected, immediately cooled to 0°C,
minced with a razor blade to paste-like consistency,
suspended in 1/15M phosphate buffer, pH 7.5, and
rendered isoosmolar to plasma by addition of NaC1
(0.05M) at 0°C. The suspension was centrifuged at
1200 x g for 90 sec, the supernatant discarded and the
pellet resuspended after passage through a 25-gauge
hypodermic needle (Sherwood Medical Industries,
Ref. G 25 x 15/16). This procedure was repeated five
times. The final pellet contained isolated glomeruli
without Bowman's capsule (Fig. 1). The preparation of
isolated glomeruli was used immediately for either
binding or glomerular vasoreactivity studies.
Binding experiments. The binding of 1251-angiotensin
II to isolated rat glomeruli was studied at 22°C using
60 g of glomerular protein in each tube. The incuba-
tion medium consisted of 200 .d of 1/15 M phosphate
buffer, pH 7.5, in 0.05 M NaCl with 2% bovine serum
albumin and 125 .g/ml of 1—24 adrenocorticotropic
hormone (ACTH) fragment (Ciba Geigy, Basel,
Switzerland). This latter peptide was added to inhibit
the inactivation system of angiotensin II without
affecting binding kinetics [9]. Standard incubation
time was 12 mm. Glomerular bound and unbound
radioactivity were separated by filtration through a
filter (Millipore, HAWP 02500). 125J was determined
with a crystal-type scintillation detector of 30% effi-
ciency and specific binding calculated by subtracting
binding in the presence of a high concentration of un-
labelled angiotensin 11(10-6 M) from total binding.
Protein determinations were performed using the
method of Lowry et al [10]. Data given in Figs. 2 to 5
represent the mean of four determinations. The SD was
less than 10% of the mean in all cases.
Degradation of bound hormone was assessed by
studying binding to fresh membranes and by poly-
acrylamide gel electrophoresis. Bound hormone was
eluted in the presence of 0.05 M acetic acid (pH 3.2)
and the eluate was neutralized with 0.1 M sodium hy-
droxide. This eluted radioactivity was then compared
with intact '251-angiotensin II. From polyacrylamide
gel electrophoresis, according to Corvol et al [6], the
ratio radioactivity of the peak corresponding to 125J..
angiotensin II Rf over total radioactivity was calcul-
ated. Binding to fresh membranes at equilibrium was
also determined for identical radioactive concentra-
tions of intact tracer and eluted hormone.
Glomerular vasoreactivity experiments. Diameters of
isolated glomeruli were measured with a micrometer
under light microscopy at 22°C as a function of 125!..
angiotensin II concentration. At each hormonal con-
centration used, a test system of glomeruli suspended
Fig. 1. Photomicrograph of isolated rat glomeruli. Only capillary tufts are present. Bowman's capsule has
been eliminated (magnification, x 250).
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in 1/15 M phosphate buffer, pH 7.5, 0.05 M NaC1 plus
'25J-angiotensin II was prepared and compared with a
control preparation in the absence of hormone. Both
preparations were examined after 12 mm of incuba-
tion. The diameter of each of ten glomeruli was
measured over approximately 1 mm (11 mm, 30 sec,
to 12 mm, 30 sec, incubation). The diameter of any
given glomerulus varied according to the direction
selected, but this was randomly chosen. Measurement
of glomerular diameter at a specific given time (12 mm)
limited the number of measurements possible.
Measurement of the diameters of ten glomeruli once
only was preferred to several measurements of the dia-
meter of fewer glomeruli. In order to avoid statistical
bias, personnel preparing the solutions differed from
those measuring glomerular diameters. Diameters of
isolated glomeruli at l0° M were also measured un-
der identical conditions as a function of time. Curves
obtained using '251-angiotensin II were compared to
those observed in the presence of unlabelled angio-
tensin II at identical concentrations. Percentage de-
crease of glomerular diameter related to glomerular
diameter at zero dose or zero time was used as an
index of glomerular vasoconstriction and, hence,
glomerular vasoreactivity.
Results
Binding studies. '251-angiotensin II binding was
measured as a function of time at varying hormonal
concentrations between 5x 10l M and 1.7x 10 M.
Equilibrium was reached after 10 to 15 mm. Specific
binding represented more than 95% of total binding.
Nonspecific binding was entirely due to physical bind-
ing to the Millipore filters as measured by binding in
the test system which did not contain receptor protein.
'S Addition of
unlabelled angiotensin II
5x10M
1.34 bPTH
CTS
ID
S
.i
Fig. 2. Uptake of 1251-angiotensin 11(1.7 x 10-10 M) by isolated rat
glomeruli (closed circles). After 12 mm of incubation, unlabelled
angiotensin 11(5 x IO M) was added in a parallel experiment
(crosses).
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Fig. 5. Inhibition of binding of'211-angiotensin 11(10-10 M) in the
presence of increasing doses of unlabelled angiotensin II. The
inhibitory effects of angiotensin 1, asp°-ileu°-angiotensin II,
sarc'-ileu°-angiotensin II, salmon calcitonin (CTS) and 1—34
bovine parathyroid hormone (bPTH) at 10 atwere also tested.
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Fig. 3. Binding of 5I-angiotensin 11(10- 10 M) asafunction of the
concentration of glomerular protein. The coefficient of correlation
(r) of the regression line is shown.
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Fig. 4. Binding of 1251-angiotensin II at equilibrium (12 miii)
plotted against log10 concentration of monoiodinated purified 11
angiotensin II. KD for high affinity receptor sites is calculated as
the concentration corresponding to 50% of the extrapolated
plateau.
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Glossmann, Baukal and Catt [9] in their studies on
adrenal angiotensin II receptors have also shown that
nonspecific binding was entirely due to physical ab-
sorption by the filter and that the presence of excess
(10-6 M) hormone did not augment nonspecific bind-
ing. At steady state, addition of 5 x 10-s M unlabelled
angiotensin II produced rapid dissociation of the
bound radioactivity from rat glomeruli (Fig. 2). The
decrease in bound radioactivity represented release of
1251-angiotensin II and not degradation of the tracer or
receptor, or both, as evidenced by the persistence of the
steady state in the absence of an excess of unlabelled
molecules. Four time-course studies were performed.
Association (k1) and dissociation (k_1) constants
were derived once from the combination of two asso-
ciation curves and three times from the combination of
an association and a dissociation curve. Assuming that
the hormone binds reversibly to a homogeneous popu-
lation of independent binding sites, the formation of
the hormone-receptor complex (RH) is rendered by the
following equation:
loge RHeqRH
= (k1H + k -
in which RHeq is the concentration of RH at equili-
brium and H the hormonal concentration in the
medium. Since less than 5% of hormonal molecules
are bound to the receptor at equilibrium, H can be
taken as a constant. The dissociation curve can be
assumed to follow the first-order rate equation:
RHlog0--— = —k_1t.
eq
A good linear fit was obtained when these equations
were applied to the experimental data. The correlation
coefficient r was 0.987 0.010 in five association studies
and 0.944 0.0 18 in three dissociation studies (mean
SD). Calculations of k1 and k_1 from the slope of the
regression lines gave the values k1 =0.254 0.078 x
lob M' min' and k_1=0.102±0.018 min'. The
ratio k_l/kl(KD) was 4.51 1011M (mean±
SEM). The dissociation t- value (loge2/k_j) was 6.8 mm
(Table 1).
'251-angiotensin II binding at 12 mm was linearly
related to the amount of receptor protein in the assay
medium at concentrations between 100 and 500 ig/ml
(Fig. 3) and, thus, binding could be expressed as
fmole/mg of glomerular protein.
After steady state was reached (12 mm in the pre-
sence of 1.7 x 10_b M '251-angiotensin II), bound hor-
mone was eluted and examined by polyacrylamide gel
electrophoresis and rebinding experiments. About8O%
was undegraded when compared to the intact tracer
(Table 2).
1251-angiotensin II binding was measured as a func-
tion of hormonal concentration at equilibrium after
12 mm of incubation (Fig. 4). An S-shaped curve was
obtained for concentrations of '251-angiotensin II
ranging from 102 M to 1.7x 10_b M, compatible
with the presence of low capacity-high affinity re-
ceptor sites. At concentrations of '251-angiotensin II
above 1.7x 10b0 M, there was a rapid increase in
bound radioactivity and this part of the curve prob-
ably reflected the presence of large capacity-low affinity
receptor sites. K of the high affinity receptor sites
could be calculated from the concentration of total
hormone corresponding to 50% of the extrapolated
plateau as free hormone always represented more than
Table 1. Indexes of binding
Experimental procedure k+1
M min1
k_1
min
K06
M
K00
M
K0°
M
Nof bind-
ing sites
fmole/mg
Hormone-receptor association
kinetics for two hormonal 0.218x101° 0.103 0.470x 10-10 — —
concentrations
Hormone-receptor association 0.474x 1010 0.149 0.314x 10
and dissociation kinetics at 0.213x10'° 0.093 0.438x 10-10 — —
a similar hormonal concen- 0.109 x 1010 0.064 0.583 x 10-10
tration
Hormone-receptor binding as 3.2x 10_il 1.24x 10_b 35.5
a function of hormonal — — — 15 x 10_li 6.49 x 10'° 66.6
concentration 7x 10_li 1.41 x 10_10 9.1
Mean±sD 0.254±
0.156 x 1010
0.102±
0.036
0.451
0.110 x 10-'°
8.4±
6 x 10_il
3.05±
2.98>< 10'°
37.1
28.8
6 K0 derived from kinetic studies (K0 =
O K0 derived from the concentration at 50% maximum binding
° K0 derived from Scatchard's plot (reciprocal of the slope).
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Binding to fresh Percentage of
membranes after radioactivity re-
12 mm of incuba- covered in the
tion at 5 x 10_12 M '251-A jia peak
fmole/mg on polyacryl-
amide gel
electrophoresis
%
Intact 1251-A II 0.458 0.327 94.0
(a)
Eluted 1251-A II 0.352 0.280 79.3
(b)
Undegraded hor-
mone, % 76.9 85.6 84.4
(x10o)
125J II, 12'I-angiotensin II.
95°/ of total hormone. This KD was 8.4±6x 10-" M
(mean SD), of the same order as that calculated from
time course studies. Scatchard's plot transformation
was used to calculate the number of sites. The very
low B/F (bound over free '251-angiotensin II) values
made this calculation less precise than that derived
from time course studies. KD and number of sites were
3.05 2.98 x 10'° M and 37.1 28.8 fmole/mg, re-
spectively (Table 1).
Dilution of 1251-angiotensin II (l0'° M) with in-
creasing concentrations of unlabelled angiotensin II
from 10-" to l0 M decreased the percentage of
labelled glomerular-bound hormone. Residual binding
above 10-6 M was less than l0%. Angiotensin I,
asparaginyl'-ileu'-ileu8-angiotensin II and sarcosine'-
ileu8-angiotensin II were all equally effective as com-
petitive inhibitors of '251-angiotensin II binding. These
two latter peptides are antagonists of angiotensin II
with little or no intrinsic activity. On the contrary,
salmon calcitonin and the 1—34 fragment of bovine
parathyroid hormone did not inhibit binding when
added at this same concentration of 10 M (Fig. 5).
Glomerular vasoreactivity studies. The percentage
decrease of glomerular diameter after 12 mm of in-
cubation was plotted against log10 concentration of
'251-angiotensin II. A sigmoidal effect vs. log dose curve
was obtained (Fig. 6a). The calculated KD (concentra-
tion of angiotensin II corresponding to 50% of the
plateau) was 5 x 10-" and 6 x 10- 11 M in two separate
experiments, respectively. These values are similar to
those obtained when binding was plotted as a function
of the log hormonal concentration (Table 2). A curve of
the same shape was derived using unlabelled angio-
tensin II. The same KD could be calculated (5 x 10"M)
b
Fig. 6. a, Percentage decrease of glomerular diameter at 12 mm of
incubation plotted against log,, concentration of monoiodinated
purified "I-angiotensin II. Each point represents the mean of ten
determinations, and each vertical bar, twice the SEM. The per-
centage decrease is related to the glomerular diameter at zero
concentration of '251-angiotensin IT. K,, was calculated as the
concentration of total hormone corresponding to 50% of the
plateau. b, Percentage decrease of glomerular diameter plotted
against time in the presence of 10-10 M 1251-angiotensin II. Each
point represents the mean of ten determinations, and each verti-
cal bar, twice the SEM. The percentage decrease is related to the
glomerular diameter at zero time.
demonstrating that labelled and unlabelled molecules
display the same affinity for rat glomeruli. However,
maximal decrease in glomerular diameter was slightly
higher with unlabelled angiotensin II, indicating that
the tracer had lost a portion of its biological potency.
Time course studies plotting percentage decrease of
glomerular diameter against time for a given 1251..
angiotensin II concentration were also performed.
A plateau was reached between 10 and 15 mm as in the
binding studies (Fig. 6b).
Table 2. Degradation of eluted hormone after 12 mm of
incubation
10_12 10—'-' 10_b 10' 108
4)H
+1
E
'4
M
a
'251-angiotensifl II
(1.7x 1010M)
5 10 12 20
mm
Discussion
The specificity of binding of '251-angiotensin II to
isolated rat glomeruli is demonstrated by the following:
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very low calculated KD, about 5 x 10h1 M, indicating
high affinity of the hormone for its receptor; specific
inhibition of binding of labelled angiotensin II by un-
labelled hormone and by antagonists; reversibility of
binding, independent of the degradation of either hor-
mone or receptor; and only minor degradation of the
eluted hormone which bound anew to fresh mem-
branes demonstrating nonidentity of the receptor and
catabolic sites.
The inhibition of binding by angiotensin I can be
interpreted as due to transformation of angiotensin I
to angiotensin II in the presence of converting enzyme
which has been found in isolated glomeruli prepara-
tions [10, 11]. The precise localization of angiotensinil
binding sites in rat glomeruli was not determined in the
present study. Osborne et a! [4] have suggested that
they are located in mesangial cells.
A specific relation between binding sites as demon-
strated in rat glomeruli and glomerular vasoreactivity
is suggested by the calculated K (about 5 x 10-11 M,
slightly higher than the physiological arterial plasma
concentration in man [12] and probably in the range of
values predicted in the rat from measurements of
plasma renin activity [13]) and the close correlation
between log-dose effect curve and log-dose binding
curve from which similar K values were derived.
High affinity binding sites were amenable to study in
these experiments because of the high specific activity
of the tracer, 40 times that of tritiated angiotensin II.
This probably explains the much lower KD observed in
the present study compared with that of Meyer et al
[15], who demonstrated specific angiotensin II re-
ceptors in smooth muscle cells from the rabbit aorta.
Conversely, our results are in the range of those ob-
tained by Glossmann, Baukal and Catt [9] with 125J..
angiotensin II on high affinity receptors in the rat
adrenal cortex, 1.85 x 10b0 M and 12 fmole/mg for
KD and number of sites, respectively. In order to com-
pare the KD found in the present study with the equili-
brium association constant (K) observed by Gloss-
mann et al, the reciprocal of K must be calculated as K
is defined as the ratio k1/k . The ability of purified
monoiodinated '251-angiotensin TI to bind to receptors
and produce physiological changes indicates that its
effective biological potency is preserved and that the
observed minor loss of potency is not of practical
significance.
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